Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.86 USD | +0.68% | -2.64% | -19.23% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.23% | 248M | C | ||
+15.84% | 38.69B | C | ||
-.--% | 11.47B | - | B+ | |
+3.38% | 6.63B | B- | ||
-1.21% | 6.32B | B+ | ||
-1.33% | 5.92B | B | ||
-11.01% | 5.59B | - | C- | |
+29.68% | 5.12B | B- | ||
-12.23% | 4.66B | C+ | ||
+3.93% | 3.89B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AVD Stock
- Ratings American Vanguard Corporation